January, come a year after the drugmaker slashed 7 percent of the workforce at Kite Pharma, its cell therapy business.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback